Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › ubrogepant

ubrogepant

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of ubrogepant

5 trials tracked of ubrogepant: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 36 citations.

5Trials tracked
4Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 1 Phase 3 3 Phase 1 1
  1. Phase 3 Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine Completed · 36 cited
  2. Phase 3 Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine Completed · 36 cited
  3. Phase 3 An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine Completed · 26 cited
  4. Phase 4 Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine Completed · 13 cited
  5. Phase 1 Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.